title: Treatment of rhabdomyosarcoma and other malignant mesenchymal tumours of childhood with ifosfamide + vincristine + dactinomycin (IVA) as front-line therapy (a SIOP study).
authors.affiliation: A. Z. K.-V. U. B., Brussels, Belgium.
authors.forename: J
authors.initials: J
authors.lastname: Otten
authors.forename: F
authors.initials: F
authors.lastname: Flamant
authors.forename: C
authors.initials: C
authors.lastname: Rodary
authors.forename: M
authors.initials: M
authors.lastname: Brunat-Mentigny
authors.forename: L
authors.initials: L
authors.lastname: Dutou
authors.forename: D
authors.initials: D
authors.lastname: Olive
authors.forename: E
authors.initials: E
authors.lastname: Quintana
authors.forename: P A
authors.initials: PA
authors.lastname: Voûte
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D003609:Dactinomycin / Q000008:administration & dosage; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D008637:Mesenchymoma / Q000188:drug therapy*; D012208:Rhabdomyosarcoma / Q000188:drug therapy*; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D003609:Dactinomycin; D014750:Vincristine; D007069:Ifosfamide